Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Evaluating the efficacy and microenvironment changes of HER2 + gastric cancer during HLX02 and Endostar treatment using quantitative MRI

Fig. 1

Tumour growth within 20 days in Groups 1, 2, 3 and 4. Seven rats were measured and averaged in each group. The smallest tumour volume with the highest tumour inhibition rate was observed in Group 4 at the end of treatment, followed by Groups 3, 2, and 1. *P < 0.05, **P < 0.01, and ***P < 0.001 were generated from comparisons between the four groups at each time point using one-way analysis of variance

Back to article page